WealthPLAN Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WealthPLAN Partners's LLY Position: Q2 2026 in Review
WealthPLAN Partners reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $15.3K and leaving 785 shares worth $942K. The position accounts for 0.18% of the portfolio, ranked #110.
WealthPLAN Partners first reported a position in LLY in Q4 2015 and has held it in 23 quarters since. The position peaked at $2.46M in Q3 2025. 1,778 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- WealthPLAN Partners held 785 shares of Eli Lilly worth $942K as of Q2 2026.
- WealthPLAN Partners sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
- Eli Lilly made up 0.18% of WealthPLAN Partners's portfolio in Q2 2026, its #110 holding.
- WealthPLAN Partners first reported a position in Eli Lilly in Q4 2015 and has held it in 23 quarters since.
- WealthPLAN Partners's Eli Lilly position peaked at $2.46M in Q3 2025.
- 1,778 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on WealthPLAN Partners's 13F filing for Q2 2026, filed 28 Jul 2026.